ProfileGDS5678 / 1429339_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 38% 39% 36% 58% 45% 37% 36% 38% 37% 42% 38% 38% 39% 38% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.9004438
GSM967853U87-EV human glioblastoma xenograft - Control 22.8819639
GSM967854U87-EV human glioblastoma xenograft - Control 32.8189536
GSM967855U87-EV human glioblastoma xenograft - Control 43.4508458
GSM967856U87-EV human glioblastoma xenograft - Control 53.014845
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.9279737
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.8816936
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.8456338
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.8216737
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.949742
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.8685538
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.8239838
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.8853239
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.8749238